Key Drivers
- High revenue volume
- Thin profitability
- Negative equity/liquidity
AIAI Summary
Cardinal Health has shifted from a low‑margin distributor into a cash‑generating, specialty‑focused operator whose re‑rating now depends on flawless execution of multiple integrations and sustained specialty margin expansion—if CAH meets FCF/deleveraging targets and reclaims 223–230 on volume the upside is material, but missed integrations, tariff or financing shocks would quickly erase gains.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High revenue volume
- •Thin profitability
- •Negative equity/liquidity
Cardinal Health is a high‑volume, cash‑generative distributor with thin margins and manageable absolute debt but concerning liquidity and negative shareholders' equity that raise solvency risk. #balance-sheet
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Clustered resistance
- •Support testing
CAH is in a short-term downtrend after closing well below its last-month SMA and losing ground from ~$229.88 to $207.88, with immediate support at ~$207.88 and clustered resistance at $223–$230 that must be reclaimed to resume bullish momentum.
Rapid decline from ~$229.88 (early
Sentiment & News
Key News Insights:
- •Strong cash flow
- •Specialty acceleration
- •Institutional shifts
Cardinal Health is reporting strong free cash flow and accelerating specialty/biosimilars momentum with robust revenue/EPS guidance, driving generally positive share performance amid active institutional repositioning.
The combination of solid cash generation and expanding specialty/biosimilars exposure should support valuation upside and confidence in execution, though investor reallocations could add near-term volatility
Similar Companies in Healthcare
Other companies in the same sector with AI ratings